Equities Analysts Offer Predictions for Danaher Q1 Earnings

Danaher Co. (NYSE:DHR) – Equities researchers at William Blair dropped their Q1 2025 EPS estimates for shares of Danaher in a note issued to investors on Thursday, January 30th. William Blair analyst M. Larew now forecasts that the conglomerate will earn $1.62 per share for the quarter, down from their prior forecast of $2.00. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. William Blair also issued estimates for Danaher’s Q3 2025 earnings at $1.94 EPS, FY2025 earnings at $7.62 EPS and Q1 2026 earnings at $1.81 EPS.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same period in the previous year, the firm earned $2.09 EPS.

Other equities analysts have also issued research reports about the company. Guggenheim initiated coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. KeyCorp increased their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Royal Bank of Canada restated an “outperform” rating and issued a $277.00 price objective (down from $299.00) on shares of Danaher in a report on Thursday. Stifel Nicolaus lifted their target price on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. decreased their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Six investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Stock Down 0.2 %

Shares of NYSE:DHR opened at $222.56 on Monday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $235.40 and a two-hundred day simple moving average of $253.08. Danaher has a 12-month low of $221.34 and a 12-month high of $281.70. The stock has a market capitalization of $160.75 billion, a price-to-earnings ratio of 42.15, a PEG ratio of 4.22 and a beta of 0.83.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in DHR. Wedge Capital Management L L P NC boosted its position in shares of Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 38 shares during the last quarter. Meridian Financial Partners LLC increased its holdings in shares of Danaher by 4.4% in the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock worth $266,000 after purchasing an additional 40 shares during the last quarter. Kovack Advisors Inc. lifted its position in shares of Danaher by 3.4% in the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after buying an additional 41 shares in the last quarter. Well Done LLC boosted its stake in Danaher by 1.2% during the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock valued at $987,000 after buying an additional 42 shares during the last quarter. Finally, Waypoint Capital Advisors LLC raised its holdings in shares of Danaher by 0.9% during the 3rd quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock worth $1,257,000 after acquiring an additional 42 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.49%. Danaher’s payout ratio is currently 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.